๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Fuzhou
Clinical trial register · China

Clinical Trials in Fuzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Fuzhou 45 Longyan 1 Quanzhou 1 Xiamen 1 Zhangzhou 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca62 First Affiliated Hospital of Fujian Medical University45 Merck Sharp & Dohme LLC39 Fujian Medical University Union Hospital39 Fujian Cancer Hospital35 Clear sponsor filter
Site location
Fuzhou45 Longyan1 Quanzhou1 Xiamen1 Zhangzhou1
All 5 locations
Target enrolment
to

Trials with a site in Fuzhou

45 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3
NCT07743866Spinocerebellar Ataxia Type 3
First Affiliated Hospital of Fujian Medical University
Not applicable
24
Fuzhou
2026-08-07
Not yet open
A Multicenter Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as Neoadjuvant Therapy for Resectable ALK-Positive Non-Squamous Non-Small Cell Lung Cancer
NCT07771764ALK-positive Non Small Cell Lung Cancer
First Affiliated Hospital of Fujian Medical University
Phase 2
30
Fuzhou, Longyan, Quanzhou, Xiamen, Zhangzhou
2026-08-01
Recruiting
Preventive Narrative Exposure Intervention for PTSD in ICU Patients After Cardiopulmonary Bypass Cardiac Surgery
NCT07632131Cardiopulmonary Bypass, Intensive Care Units, Stress Disorders, Post-Traumatic
First Affiliated Hospital of Fujian Medical University
Not applicable
100
Fuzhou
2026-06-02
Recruiting
Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT07562438Prostate Cancer
First Affiliated Hospital of Fujian Medical University
Phase 2
20
Fuzhou
2026-04-29
Recruiting
Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease
NCT07513844Huntington Disease
First Affiliated Hospital of Fujian Medical University
Not applicable
24
Fuzhou
2026-04-20
Recruiting
Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome
NCT07547098Cardiovascular Diseases (CVD), Chronic Kidney Disease, Metabolic Diseases, Cardiovascular-kidney-metabolic Syndrome
First Affiliated Hospital of Fujian Medical University
Observational
8,000
Fuzhou
2026-03-01
Recruiting
Comparing Different Doses of Corticosteroids in Local Infiltration Analgesia (LIA) for Total Knee Arthroplasty
NCT07337772Adrenal Cortex Hormones, Arthroplasty, Replacement, Knee, Anesthesia, Local
First Affiliated Hospital of Fujian Medical University
Not applicable
120
Fuzhou
2026-02-01
Recruiting
Evaluation of AI Large Models for Diagnosis and Treatment in Real-World Cases: Multicenter Retrospective Study
NCT07378358Urologic Diseases
First Affiliated Hospital of Fujian Medical University
Observational
800
Fuzhou
2026-01-01
Recruiting
The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer
NCT07363382Prostate Cancer (Adenocarcinoma)
First Affiliated Hospital of Fujian Medical University
Phase 1/2
6
Fuzhou
2025-12-20
Recruiting
Rifampin-combined Antibiotic Therapy for Staphylococcal PJI
NCT07313215Periprosthetic Joint Infection
DrugRifampicin
First Affiliated Hospital of Fujian Medical University
Not applicable
428
Fuzhou
2025-11-13
Recruiting
Taining Golden Lake Comprehensive Chronic Disease Management Initiative
NCT07308314Chronic Disease, Chronic Disease Management, Hypertension, Diabetes Mellitus
First Affiliated Hospital of Fujian Medical University
Observational
20,000
Fuzhou
2025-08-01
Recruiting
PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension
NCT07131241Pulmonary Hypertension
First Affiliated Hospital of Fujian Medical University
Observational
1,000
Fuzhou
2025-06-27
Recruiting
Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance
NCT07257562Chronic Hepatitis B
DrugBranched-Chain Amino Acids
First Affiliated Hospital of Fujian Medical University
Observational
40
Fuzhou
2025-06-01
Recruiting
Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer
NCT07056790Prostate CA
First Affiliated Hospital of Fujian Medical University
Phase 1/2
40
Fuzhou
2025-05-15
Recruiting
PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS โ‰ค3 and Prior Negative Biopsy
NCT06923657Prostate Cancer Screening, PSMA-PET
First Affiliated Hospital of Fujian Medical University
Not applicable
230
Fuzhou
2025-05-07
Active, closed
Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT07117760Prostate Cancer
Drugs225Ac-LNC1011·68Ga-PSMA-11
First Affiliated Hospital of Fujian Medical University
Phase 1/2
16
Fuzhou
2025-04-22
Recruiting
Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT07363486Prostate Cancer
Drug225Ac-LNC1011
First Affiliated Hospital of Fujian Medical University
Phase 1/2
9
Fuzhou
2025-04-01
Active, closed
Clinical Study of 177Lu-JH040182 in Patients With FAP-Positive Malignancies
NCT07681141Patients With Advanced Metastatic FAP-Positive Tumors
First Affiliated Hospital of Fujian Medical University
Phase 1
3
Fuzhou
2025-04-01
Active, closed
Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study
NCT06917560Renal Carcinoma, Serology, Autoantibody
First Affiliated Hospital of Fujian Medical University
Observational
400
Fuzhou
2025-04-01
Recruiting
Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73
NCT06995976Malignant Tumour
Drug18F-FDG
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
30
Fuzhou
2025-03-01
Recruiting
Multi-center Clinical Study on Hemoperfusion of KHA80
NCT06233838Uremia, Uremic Osteodystrophy, Dialysis Related Complication
First Affiliated Hospital of Fujian Medical University
Not applicable
394
Fuzhou
2025-01-13
Active, closed
Analysis of Immediate Urinary Continence Predictors After RS-RARP
NCT06850116Prostate Cancer (Post Prostatectomy), Urinary Continence, Retzius-sparing Robot-assisted Radical Prostatectomy
First Affiliated Hospital of Fujian Medical University
Observational
400
Fuzhou
2025-01-01
Recruiting
68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study
NCT06688188Malignant Neoplasm
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
5
Fuzhou
2024-11-01
Recruiting
Analgesic Efficacy of Preemptive Stepwise Infiltration Anesthesia for Perioperative Analgesia After TKA
NCT06600815Total Knee Arthroplasty, Pain Management
First Affiliated Hospital of Fujian Medical University
Not applicable
110
Fuzhou
2024-09-30
Active, closed
Analysis of Predictive Factors for Urinary Leakage After Partial Nephrectomy for Renal Hilum Tumors
NCT06916910Partial Nephrectomy, Renal Hilum Tumors, Urinary Leakage
First Affiliated Hospital of Fujian Medical University
Observational
200
Fuzhou
2024-09-18
Recruiting
68Ga-AAZTA-NI-093 PET/CT: First-in-human Study
NCT06612580Prostate Cancer (Adenocarcinoma)
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
10
Fuzhou
2024-09-01
Recruiting
177Lu-JH04 in Patients with FAP-Positive Tumors
NCT06636617Patients with Advanced Metastatic FAP-Positive Tumors
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
9
Fuzhou
2024-08-21
Recruiting
FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer
NCT06421142Urinary Bladder Neoplasms
First Affiliated Hospital of Fujian Medical University
Not applicable
80
Fuzhou
2024-08-02
Recruiting
68Ga-NI-FAPI PET/CT: First-in-human Study
NCT06688305Malignant Neoplasm
Drug68Ga-NI-FAPI
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
40
Fuzhou
2024-08-01
Active, closed
Predicting HIF-2ฮฑ Levels in Clear Cell Kidney Cancer Using Machine Learning
NCT07332923Renal Clear Cell Carcinoma, HIF-2ฮฑ, Radiomics, Nomogram
First Affiliated Hospital of Fujian Medical University
Observational
500
Fuzhou
2024-08-01
Recruiting
18F-FAPIBiotin PET/CT: Dosimetry and Biodistribution Study
NCT06734572Malignant Neoplasm
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
5
Fuzhou
2024-06-25
Recruiting
Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer
NCT06791083Gastric Cancer
DrugsEnvafolimab·Fruquintinib
First Affiliated Hospital of Fujian Medical University
Phase 2
40
Fuzhou
2024-06-20
Recruiting
68Ga-JH04 PET/CT: Dosimetry and Biodistribution Studies
NCT06438250Malignant Neoplasm
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
5
Fuzhou
2024-03-01
Recruiting
68Ga-FAPI-Biotin PET/CT in Patients With Various Types of Cancer
NCT06740240Tumor
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
30
Fuzhou
2024-03-01
Recruiting
Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes
NCT06977906Robotic-Assisted Radical Prostatectomy, Locally Advanced Prostate Cancer, Bladder Suspension
First Affiliated Hospital of Fujian Medical University
Not applicable
300
Fuzhou
2024-01-01
Recruiting
A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies
NCT06181032Biliary Tract Malignancies
DrugsApatinib·Adebrelimab·Gemcitabine·Cisplatin
First Affiliated Hospital of Fujian Medical University
Phase 1
35
Fuzhou
2023-12-23
By invitation
CLIME-CJD: A Multimodal Study
NCT07589283Creutzfeldt-Jakob Disease (CJD) | Prion Disease
First Affiliated Hospital of Fujian Medical University
Observational
150
Fuzhou
2022-01-01
Recruiting
Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.
NCT05284318Periprosthetic Joint Infection, Anti-Bacterial Agents
First Affiliated Hospital of Fujian Medical University
Observational
500
Fuzhou
2021-12-01
Recruiting
Safety and Efficacy of Stereotactic Aspiration Plus Urokinase in Deep Intracerebral Hemorrhage Evacuation
NCT04686877Treatment of Spontaneous Intracerebral Hemorrhage
First Affiliated Hospital of Fujian Medical University
Not applicable
400
Fuzhou
2021-01-31
Recruiting
Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of SAAE
NCT05188872Positron-Emission Tomography
First Affiliated Hospital of Fujian Medical University
Not applicable
100
Fuzhou
2020-09-01
Recruiting
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
NCT04499365Tumor, Positron-Emission Tomography, Metastasis
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
500
Fuzhou
2020-08-15
Recruiting
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
NCT04504526Lymphoma, Multiple Myeloma, Leukemia
Drug68Ga-pentixafor
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1
50
Fuzhou
2020-08-07
Recruiting
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
NCT07209878Prostate Cancer (Adenocarcinoma)
Drug68Ga-PSMA-11
First Affiliated Hospital of Fujian Medical University
Phase 2/3
100
Fuzhou
2020-01-10
Recruiting
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
NCT04008329Amyotrophic Lateral Sclerosis
First Affiliated Hospital of Fujian Medical University
Observational
2,000
Fuzhou
2019-07-05
By invitation
A Registered Observational Cohort Study of Myotonic Dystrophy Type 1
NCT06979024Myotonic Dystrophy Type 1 (DM1)
First Affiliated Hospital of Fujian Medical University
Observational
300
Fuzhou
2008-01
Rows per page Showing 1–45 of 45
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/fuzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 45 of those studies with a site in Fuzhou that also match the filters currently applied.

How many clinical trials are recruiting in Fuzhou?

35 of the 45 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 6 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Fuzhou), 45 studies
PhaseStudiesRecruitingShare
Observational13728.9%
Not applicable121126.7%
Phase EARLY_PHASE1101022.2%
Phase 1/2438.9%
Phase 2326.7%
Phase 1214.4%
Phase 2/3112.2%

Most active sponsors

Lead sponsors with the most studies (Fuzhou)
Lead sponsorStudiesRecruiting
First Affiliated Hospital of Fujian Medical University4535
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.